Search

Displaying results 7351 - 7360 of 8970 in total
  1. Drug

    Landipirdine

    go.drugbank.com/drugs/DB16214
    Investigational

    Landipirdine is under investigation in clinical trial NCT02258152 (SYN120 Study to Evaluate Its Safety, Tolerability and Efficacy in Parkinson's Disease Dementia (SYNAPSE)).

  2. Drug

    Octovalent O-polysaccharide-toxin A conjugate vaccine

    go.drugbank.com/drugs/DB17789
    Experimental

    Octovalent O-polysaccharide-toxin A conjugate vaccine is currently being investigated to treat Pseudomonas Aeruginosa infection in patients with cystic fibrosis.[A259462]

    Synonyms: Octovalent O-polysaccharide-toxin A conjugate vaccine, octavalent Psuedomonas aeruginosa O-polysaccaharide-toxin A conjugate
  3. Drug

    DCN-tCRK

    go.drugbank.com/drugs/DB18262
    Experimental

    DCN-tCRK is a recombinant, multi-functional fusion protein consisting of human decorin fused to the C-terminal vascular homing peptide tCRK.

  4. Drug

    MB-107

    go.drugbank.com/drugs/DB18566
    Experimental

    MB-107 consists of mobilized peripheral blood-derived autologous CD34+ hematopoietic stem cells that are genetically modified to express the IL2RG gene.

  5. Drug

    Allitinib

    go.drugbank.com/drugs/DB18840
    Experimental

    Allitinib is under investigation in clinical trial NCT04671303 (To Evaluate the Efficacy and Safety of Anlotinib Combined With Allitinib in Lung Cancer).

  6. Drug

    Obefazimod

    go.drugbank.com/drugs/DB14828
    Investigational

    ABX-464 is under investigation in clinical trial NCT03905109 (Safety Evaluation of ABX464 in Patients With Moderate to Severe Active Crohn's Disease).

  7. Drug

    (R)-acetoin

    go.drugbank.com/drugs/DB04364
    Experimental

    In mammals it is oxidized to carbon dioxide.

  8. Drug

    (S)-acetoin

    go.drugbank.com/drugs/DB02788
    Experimental

    In mammals it is oxidized to carbon dioxide.

  9. Drug

    ARG201

    go.drugbank.com/drugs/DB06621
    Experimental

    ARG201, a bovine-derived Type I collagen, aims to induce immune tolerance in patients with Diffuse Systemic Scleroderma (dcSSc).

  10. Drug

    Clopenthixol

    go.drugbank.com/drugs/DB13841
    Investigational

    Clopenthixol is a thioxanthene with therapeutic actions similar to the phenothiazine antipsychotics. It is an antagonist at D1 and D2 dopamine receptors.